ICH Q4B Annex 5 Disintegration test

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/ICH/308895/08
Effective from01/12/2009
KeywordsDisintegration test, tablets, capsules, pharmacopoeia
DescriptionThis annex is the result of the Q4B process for Disintegration Test General Chapter. The proposed texts were submitted by the Pharmacopoeial Discussion Group. It aims to facilitate the recognition of pharmacopoeial procedures for the disintegration test by regulatory authorities in the ICH regions. It describes special requirements for this test to be considered interchangable for use in the ICH regions.

Document history

First version

Current version

Adopted guideline

Draft guideline

In operation: 01/12/2009–present

Published: 01/06/2008

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more